Influenza vaccines can afford significant protection against
nfluenza illness, even when there is an antigenic mismatch
gainst the predominant circulating virus strains16,17. Such cross-
rotectioncanoccurthroughtheprimingoftheimmunesystem
y vaccination or natural infection and is primarily due to
ntibodies specific to conserved regions on the HA head and
tem18. Vaccines that can induce immunity specific to circulating
ild-typestrainsandcross-protectiontorelatedstrainswouldbe
deal against constantly evolving influenza viruses. As such, the
onserved regions on the HA head and stem present attractive
argetsfor developmentof universalinfluenzavaccines19,20.